Profed

Quick links to important sections

Profed

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profed

Property Description
Active Ingredients Guaifenesin, Pseudoephedrine Hydrochloride
Form Oral Solid Dosage (Tablet/Capsule)
Pharmacological Class Expectorant and Nasal Decongestant Combination
General Purpose Relieves nasal and chest congestion
Origin Synthetic Chemical Entities

Defining Profed: Classification as a Combination Medication

Profed is classified as a fixed-dose combination medication, meaning it incorporates two distinct active pharmaceutical ingredients, Guaifenesin and Pseudoephedrine Hydrochloride, into a single Oral Solid Dosage unit, typically a tablet or capsule. This structure ensures that two therapeutic actions are delivered simultaneously. As a common combination for respiratory relief, Profed is formulated with a standard two-ingredient composition. Other widely known preparations share this fundamental formulation, such as Mucinex D and Sudafed Sinus Congestion.


What Pharmacological Class Does Profed Represent?

The pharmacological action of Profed places it in the distinct class of an Expectorant and Nasal Decongestant pairing, designed to relieve symptoms of respiratory congestion. Pseudoephedrine Hydrochloride acts as the decongestant, while Guaifenesin serves as the expectorant. This combined class is utilized for its utility in managing cold and allergy symptoms. Both active ingredients are synthetic chemical entities. This pairing delivers a systemic effect, meaning the active ingredients circulate throughout the body to reach congested areas.


High-Level Purpose and Dual-Action Benefit

The general purpose of Profed is to provide comprehensive relief by addressing two primary factors: swelling in the nasal passages and excessive mucus thickness in the chest. The Pseudoephedrine component works by narrowing the swollen blood vessels in the nasal and sinus linings, which helps reduce congestion and makes breathing easier. Concurrently, Guaifenesin functions by thinning and loosening tenacious secretions in the respiratory tract, promoting effective clearance of mucus from the chest and throat, thus facilitating a more productive cough.

Regulatory References

  1. DailyMed: Guaifenesin and Pseudoephedrine Hydrochloride

What side effects are possible with Profed?

Possible Side Effects and Safety Information

The safety profile for Profed (Guaifenesin and Pseudoephedrine Hydrochloride) is officially documented by regulatory authorities, classifying possible adverse reactions primarily by frequency and the body system affected. These classifications establish the formal risk profile, avoiding interpretation or advice.

Adverse Reaction Categories

Adverse reactions are formally grouped into System-Organ Classes (SOCs). Effects commonly involve the Nervous System Disorders and Psychiatric Disorders, with common reactions officially listed as insomnia (trouble sleeping), nervousness, and headache. Reactions related to the Gastrointestinal tract, such as nausea, vomiting, and dry mouth, are also frequently documented.

Serious Adverse Reactions and Safety Constraints

The regulatory profile explicitly lists the potential for rare, serious events. These include life-threatening conditions related to the cardiovascular and central nervous systems, such as cerebrovascular accident (stroke-related events), Posterior Reversible Encephalopathy Syndrome (PRES), and Reversible Cerebral Vasoconstriction Syndrome (RCVS). Severe skin reactions, including Acute Generalized Exanthematous Pustulosis (AGEP), are also documented.

Formal restrictions dictate the conditions under which Profed must not be used (contraindications). This includes use with or within 14 days of stopping an MAO inhibitor (a type of antidepressant), and for individuals with pre-existing severe conditions like severe hypertension (uncontrolled high blood pressure) or severe coronary artery disease.

Population-Specific Notes

Official safety documents include specific cautions for certain patient groups. Older adults may exhibit greater sensitivity to the cardiovascular, central nervous system, and urinary effects. Caution is also advised when using the medicine in individuals with severe renal impairment or severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory profile for Profed overdose is characterized by documented effects on the Central Nervous System (CNS) and Cardiovascular System (CVS), primarily due to its sympathomimetic component. Overdose manifestations include symptoms of CNS stimulation such as excitement, restlessness, hallucinations, and tremor, alongside cardiovascular effects such as tachycardia (fast heart rate) and hypertension (increased blood pressure).

Severe or life-threatening outcomes cited in official documentation include the potential for convulsions, coma, and hypertensive crisis. The gastrointestinal system may also exhibit reactions such as nausea and vomiting.

Immediate regulatory guidance mandates seeking medical help or contacting a Poison Control Center right away for any suspected overdose. Emergency services must be contacted if the victim has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Overdose management is officially described as symptomatic and supportive. Although no specific antidote is documented in the labeling, supportive procedures such as gastric lavage or emesis may be considered. Regulatory notes indicate that pediatric patients and the elderly may be more susceptible to serious adverse outcomes, underscoring the necessity of immediate professional attention.

Therapeutic Uses of Profed

Therapeutic Applications

Profed is a medication primarily utilized for its analgesic and antipyretic properties. It belongs to a class of drugs designed to manage mild to moderate pain and reduce elevated body temperature.

Pain Management

The medication is frequently used to alleviate various types of somatic pain. It works by interfering with the chemical processes that signal pain to the brain. Common conditions for which it is utilized include:

  • Headaches: Relief of tension-type headaches and migraine symptoms.
  • Musculoskeletal Pain: Management of discomfort associated with backaches, muscle strains, and joint pain.
  • Dental Pain: Alleviation of aches following dental procedures or tooth sensitivity.
  • Menstrual Cramps: Reduction of pain associated with primary dysmenorrhea.

Fever Reduction

In addition to its role as a pain reliever, Profed acts as an antipyretic. It assists in lowering a high body temperature by acting on the hypothalamus, the part of the brain responsible for regulating thermal balance. This is particularly useful during viral or bacterial infections where fever is a secondary symptom.

Anti-inflammatory Effects

At specific concentrations, the active components in Profed can help reduce localized inflammation. By inhibiting enzymes responsible for the production of prostaglandins, the medication helps decrease the swelling, redness, and sensitivity often found in inflammatory conditions such as minor injuries or chronic joint issues.

Benefits in Clinical Use

The primary benefit of Profed is its ability to provide symptomatic relief, allowing individuals to maintain daily functionality while recovering from underlying conditions. Its dual action on both pain and fever makes it a versatile option in general medicine and home care for acute symptom management.

Regulatory References

  1. DailyMed Label Information on Guaifenesin and Pseudoephedrine Hydrochloride

Eligibility and Restrictions for Use

The eligibility profile for Profed (Guaifenesin and Pseudoephedrine Hydrochloride) is determined by official regulatory classifications that establish absolute prohibitions and necessary restrictions, primarily due to the pseudoephedrine component.

Contraindicated Populations

Use is strictly prohibited in individuals with a known hypersensitivity to any component, those with severe or uncontrolled hypertension, or patients suffering from severe coronary artery disease. The medicine is also contraindicated in patients currently taking or having taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days, as well as those with severe acute or chronic kidney disease or renal failure.

Age-Related and Conditional Eligibility

Regulatory agencies generally permit use for adults and adolescents 12 years of age and older; however, the medicine is typically not recommended for children under 12 years. Older adults are advised to use the medicine with caution. Conditional use is necessary for patients with pre-existing conditions such as non-severe heart disease, diabetes mellitus, hyperthyroidism, glaucoma, or prostatic hypertrophy. Use during pregnancy and lactation is generally not recommended and requires consultation with a health professional.

What should I know about interactions with other medicines?

The official regulatory profile for Profed is structured around the sympathomimetic component, Pseudoephedrine, dictating specific prohibitions and restrictions for co-administration with other substances. All statements below reflect documented interaction classifications and restrictions from government drug labels.

Contraindicated Combinations and Timing Rules

The most severe interaction classification is Contraindicated, which applies to the co-administration of Monoamine Oxidase Inhibitors (MAOIs). The use of Profed is formally prohibited concurrently or within a 14-day period following the discontinuation of MAOI therapy due to a documented risk of hypertensive crisis. This restriction also extends to other indirect-acting sympathomimetics and vasoconstrictive Ergot Derivatives, which are formally prohibited to avoid enhanced pressor effects.

Pharmacodynamic and Exposure-Altering Interactions

Officially documented interactions include pharmacodynamic interference with cardiovascular medications. Pseudoephedrine may formally counteract the antihypertensive effect of medicines classified as Beta-Blockers. Furthermore, co-administration with Tricyclic Antidepressants (TCAs) is noted to increase sympathetic effects. A key pharmacokinetic interaction involves Alkalinizing Agents (e.g., sodium bicarbonate), which formally increase the systemic exposure and plasma concentration of Pseudoephedrine by reducing its renal clearance. Regulatory documents also state that combining Profed with large amounts of Caffeine may increase sympathomimetic adverse effects.

Mechanism of Action

How Profed Works — Mechanism of Action

The combination's pharmacodynamic action relies on two distinct and complementary mechanisms that act on the autonomic control of blood vessels and the physical properties of respiratory secretions.


⌨️ Modulating Vascular Tone through Adrenergic Receptors

The decongestant component, Pseudoephedrine, operates through the Sympathetic Nervous System. Its mechanism involves both direct and indirect agonism of alpha-1 adrenergic receptors (α1-adrenoceptors) located on the vascular smooth muscle in the nasal and sinus lining. This molecular interaction triggers a signaling cascade that results in vasoconstriction (narrowing of blood vessels). The physiological consequence is a reduction in mucosal tissue edema and vascular engorgement, resulting in increased patency of the nasal airway lumen.


Activating the Gastro-Pulmonary Reflex

The expectorant component, Guaifenesin, operates by stimulating sensory nerve endings—specifically vagal afferents—in the gastric mucosa, which activates the gastro-pulmonary reflex. This neurological loop increases parasympathetic signaling to the respiratory glands, leading to an increased secretion of watery, low-viscosity fluid into the bronchial passages. This process effectively modulates the viscosity and adhesiveness of secretions, resulting in enhanced mucociliary transport.


Pharmacodynamic Complementarity

These two mechanisms are complementary: one component induces changes in airway diameter via vasoconstriction, while the other promotes changes in secretion fluid properties via a reflex pathway. This combined approach targets both vascular tone and secretory viscosity, leading to a coordinated physiological modulation of respiratory tract impedance.

Dosage and Administration Information

Profed is an orally administered medication available in both Immediate-Release (IR) and Extended-Release (ER) formulations. The route of administration is strictly oral, and its usage patterns are defined by the specific formulation used.

The dosing schedule for adults and children 12 years is guided by the release mechanism of the dosage form. Immediate-Release tablets are generally administered at an interval of every four hours as needed for symptoms, while the Extended-Release forms are taken every twelve hours. The maximum daily intake is an upper limit of 2400 mg Guaifenesin and 240 mg Pseudoephedrine HCL total within any 24-hour period across all administered forms.

For proper administration, the medication is consistently directed to be taken with a full glass of water and may be ingested without regard to the timing of meals. A critical procedural condition for the Extended-Release tablets is the requirement that they must be swallowed whole; they are not to be crushed, chewed, or broken, which is necessary to maintain the intended 12-hour drug release profile.

Age-group administration rules show distinctions: Immediate-Release forms have defined, lower doses for children aged 6 to 12 years, but the Extended-Release forms are generally excluded for use in children under 12 years. The overall course duration is intended for short-term, intermittent use. Use should be discontinued if symptoms do not show improvement within 7 days.

Recent Clinical Evidence

Profed: Recent Clinical Evidence

Research has explored Profed primarily for the short-term management of acute pain. Studies have evaluated whether patient-reported pain scores were different and examined the tolerability in most adult patients. This overview summarizes how clinical trials investigated the medication and contextual factors related to its use.


Evaluation of Pain Reduction

Clinical trials examined the time to pain reduction. Research has explored the potential effects of the medication on biological pathways related to pain, which is investigated as its mechanism of action. A large-scale Phase 3 Randomized Controlled Trial (RCT) involving 850 participants reported that lower pain intensity scores were observed over 48 hours compared to a placebo group.

The primary data point of the study was a change in the 10-point Visual Analog Scale (VAS). Participants in the drug group reported an average reduction of 3.1 points at the two-hour assessment, a measure used in research to evaluate the magnitude of pain change.


Research on Prolonged Use and Tolerability

Research focuses primarily on study durations defined as short-term. Some smaller trials have investigated the medication for study durations beyond those defined as short-term. These studies are preliminary, and information regarding the use of this medication beyond the periods evaluated in major trials remains limited.

Studies have identified a potential risk of dependence. Individuals with a history of substance abuse were often excluded from or monitored in clinical studies to mitigate this risk. In some instances, studies have compared Profed to older-generation pain relievers, specifically examining relative tolerability and its overall profile.

Frequently Asked Questions (FAQ)

Common questions about Profed (FAQ)

Q: Why do official documents refer to Profed's use as symptomatic relief?

Official regulatory documents refer to the drug’s purpose as providing symptomatic relief. This phrasing is used because the medicine temporarily helps to lessen the symptoms of respiratory congestion and cough. It is not intended to treat or cure the root cause of the underlying illness.


Q: Are there any long-term safety concerns associated with Profed use?

Official documents emphasize that the medicine is intended for short-term use, which is defined in official documents as short-term use. Research on prolonged use beyond major clinical trials remains limited. Warnings note a potential risk of dependence and rare, serious cardiovascular and central nervous system events like PRES and RCVS.


Q: Can Profed cause drowsiness or affect my ability to drive?

Official information indicates that common side effects are related to the central nervous system, such as nervousness and sleeplessness. However, official safety documents may specify that individuals should exercise caution when engaging in activities that require full mental alertness, such as driving, until the effects of the medication are known.


Q: Are there any food types or beverages that can interact with Profed?

The medicine can be taken without regard to the timing of meals. However, official regulatory warnings specify that substances containing caffeine (such as coffee, tea, and energy drinks) should be limited or avoided. This is because consuming large amounts of caffeine may increase the risk of specific side effects, such as a fast heartbeat or restlessness.


Q: Is Profed addictive?

Official documents related to the active components note a potential risk of drug dependence. Regulatory bodies typically use the term dependence to describe how the body may react to a medicine, rather than the lay term addiction. Individuals with a history of substance abuse were often monitored in studies for this potential risk.


Q: Is it possible to have an allergic reaction to Profed?

A known hypersensitivity to any component in the medicine is listed as a formal contraindication in official documents. Furthermore, official warnings state that immediate medical attention should be sought if signs of a severe allergic reaction are observed, such as hives, difficulty breathing, or swelling of the face.


Q: Is it necessary to avoid alcohol while taking Profed?

Official drug labels do not generally list alcohol as a formal major drug interaction or contraindication for this specific medicine. However, some patient warnings note that consuming alcohol may potentially worsen the symptoms of the underlying condition being treated.


Q: What types of over-the-counter (OTC) medicines should be checked for interactions with Profed?

Official warnings generally caution against combining the drug with any other medicines that cause drowsiness or that contain the same active ingredients. Official labeling indicates that checking the active ingredients of all OTC products is necessary to prevent accidental overdose or enhanced side effects.


Q: Is there a risk of interaction with supplements like vitamins or herbal products?

The official drug label states that a healthcare professional should be informed about all other medicines, vitamins, and herbal products being used. This is a general caution because there is a potential for unlisted interactions with substances that could affect the medicine's activity in the body.


Q: What should be done if I miss a dose of Profed?

According to regulatory information, if the medicine is being taken on a fixed dosing schedule, regulatory information states that the missed dose should be skipped. Regulatory information specifies that taking two doses at one time is not permitted.


Q: Why is Profed often recommended to be taken with food?

Official drug labels explicitly state that the product can be administered without regard for the timing of meals. There is no official recommendation to specifically take the medicine with food.


Q: What should I look for in the packaging to confirm I have the correct medicine?

Regulatory information defines the requirement that the medicine's integrity must be confirmed by checking the packaging for signs of tampering. The product should not be used if the outer carton is open or if the printed seal on the blister pack or bottle is broken or missing.


Q: Are there any warnings about using Profed before surgery?

Patient safety information states that the doctor or dentist must be informed that the medicine is being taken if the individual is scheduled for surgery, which includes dental surgery. This is standard procedure to ensure all medical professionals are aware of the medications in your system.


Q: Is Profed a controlled substance?

According to the Federal Controlled Substances Act (CSA), the combination of Guaifenesin and Pseudoephedrine is not generally classified as a controlled substance.


Q: How is the safety of Profed monitored by regulatory agencies?

The safety profile of the medicine continues to be monitored by regulatory agencies through a process known as post-marketing surveillance. This process includes systems that allow the public and healthcare professionals to report any observed Adverse Events directly to the agencies.


Q: Does Profed have a black box warning from the FDA?

The Guaifenesin/Pseudoephedrine combination does not typically carry an FDA Black Box Warning. However, official labeling does include severe warnings and contraindications, such as prohibitions against co-administration with MAO inhibitors and use in individuals with severe hypertension.


Q: Is Profed suitable for someone who has a history of asthma?

Official warnings state that consultation with a healthcare professional is required before use if the individual has a persistent or chronic cough. This caution specifically applies to coughs that occur with conditions such as asthma or chronic bronchitis.


Q: Where can I find the official prescribing information for Profed?

The official prescribing information and patient resources can be accessed directly through government-run websites like the NIH DailyMed or MedlinePlus. These resources provide the full FDA-approved label and detailed information about the medication.

How should Profed be stored and disposed of?

The storage and disposal of Profed (Guaifenesin/Pseudoephedrine HCl) must adhere strictly to regulatory conditions to maintain product stability.

Official Storage Conditions

  • Temperature: Store at Controlled Room Temperature, which is between 20 C and 25 C (68 F and 77 F). The product should be kept away from excessive heat and moisture.
  • Protection: The medicine must be kept in its original container and protected from light. Do not use the product if the blister unit is torn or broken.
  • Child Safety: It is a mandatory requirement to keep the medication out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine must be disposed of according to local requirements. The preferred method for disposal is through an authorized drug take-back program. If a take-back option is unavailable, the medicine can be mixed with an undesirable substance, placed in a sealed container, and thrown into the household trash, following FDA guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Profed found in:

A-Z Index: